Navigation Links
Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers
Date:2/5/2015

SAN DIEGO, Jan. 26, 2015 /PRNewswire/ -- Epic Sciences, a precision diagnostics company dedicated to improving the treatment of cancer, today announced that Murali Prahalad, Ph.D., president and CEO, is scheduled to present at the Personalized Medicine World Conference (PMWC) 2015: Silicon Valley, which is taking place at the Computer History Museum in Mountain View, Calif. on January 26-28, 2015.

Dr. Prahalad will give a presentation entitled, "CTCs Come of Age as Biomarkers." Last year, Epic Sciences was a finalist in the PMWC's Most Promising Company Award Competition.

The details of the presentation are as follows:

Date:  Tuesday, January 27, 2015
Track 1:  Applying Complementary Technologies Towards Biomarker Discovery
Time:  3:45 PM PST

Co-hosted with Stanford Health Care and Oracle in Silicon Valley, PMWC 2015 will gather close to 1,000 multidisciplinary attendees and key stakeholders from the business, government, healthcare delivery, research and technology arenas to examine the advances and challenges of personalized medicine through a practical lens.

About Epic Sciences

Epic Sciences, Inc. is developing novel diagnostics to personalize and advance the treatment and management of cancer. Epic's mission is to enable the rapid and non-invasive detection of genetic and molecular changes in cancer throughout a patient's journey. The company was founded on a powerful platform to identify and characterize rare cells, including circulating tumor cells (CTCs). Epic's no cell left behind™ technology helps match patients to targeted therapies and monitor for drug resistance, so that the best treatment path can be chosen at every clinical decision point.  Today, we partner with leading pharmaceutical companies and major cancer centers around the world. Epic's goal is to commercialize our technology to increase the success rate of cancer drugs in clinical trials and improve patient outcomes by providing physicians real-time information to guide treatment choices.

Further information is available on the Company's website, www.epicsciences.com. Stay in touch on Twitter @EpicSciences or on Facebook.com/EpicSciences.


'/>"/>
SOURCE Epic Sciences
Copyright©2015 PR Newswire.
All rights reserved

Related biology news :

1. Mellon Foundation awards grant for major project in the humanities and sciences
2. EUR 750,000 in funding for new Competence Center for HPC in the Natural Sciences at Mainz
3. New textbook introduces undergraduates to mathematics for the life sciences
4. San Antonio Life Sciences Institute awards $750,000 to innovators
5. Neurotropes Approach to Treating Alzheimers Disease Through Its Product Bryostatin-1, an Activator of Protein Kinase C Epsilon (PKCe), Supported by Blanchette Rockefeller Neurosciences Institute (BRNI) Publication, Identifying PKCe as a Biomarker
6. Salk researcher Tony Hunter to receive 2014 Royal Medal in biological sciences
7. San Antonio Life Sciences Institute awards $25,000 for stem cell research
8. Pioneer in next generation sequencing receives 2014 HudsonAlpha Life Sciences Prize
9. BioForce Nanosciences, Inc. Unveils New Molecular Printer.
10. Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB)
11. Elsevier announces the launch of a new journal: Current Opinion in Behavioral Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/30/2019)... , ... December 30, 2019 , ... It’s been quite ... has seen its highest sales in 2019, having hosted a multitude of team-building events ... all visited the company’s La Jolla-based venue, and the company has worked hard to ...
(Date:12/18/2019)... ... December 17, 2019 , ... ... biotech, medical device, and diagnostics industries, has named Pharmafusion LLC as one of ... year for the company and its founder/CEO Jonathan Retano. Earlier in the year, ...
(Date:12/4/2019)... (PRWEB) , ... December 03, 2019 , ... ... R&D, today announced that Agenus , a clinical-stage immuno-oncology company developing therapies ... their antibody R&D workflow platform. Agenus will use the platform to support immunotherapy ...
Breaking Biology News(10 mins):
(Date:1/8/2020)... (PRWEB) , ... January 08, 2020 , ... ... metal wire composites that can achieve specific properties for use in harsh environments ... Metal Wire combines up to three metals or alloys to achieve specific ...
(Date:1/7/2020)... ... January 07, 2020 , ... Vuja De Sciences (“Vuja De”), a biotechnology startup ... the appointments of Chand Khanna, DVM, PhD, DACVIM (Onc), and Dr. Lee Helman, MD, ... “We are delighted to welcome Chand and Lee as new directors. They will be ...
(Date:1/7/2020)... ... January 06, 2020 , ... ABCT , the Accelerator ... invited to participate in the annual program. Twelve ventures will participate in the ... professional network. All startups will receive an entrepreneur coach, access to active business ...
(Date:12/30/2019)... (PRWEB) , ... December 30, 2019 , ... ... built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food ... 1.11.19 21 CFR Part 11 compliant software program specific to the custom-built helium ...
Breaking Biology Technology: